First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology 》 |2018年第3期| 共6页
• 作者

  Pika Tomas; Hegenbart Ute; Flodrova Pavla; Maier Bettina; Kimmich Christoph; Schoenland Stefan O.;

  展开▼
• 作者单位

  Univ Hosp Olomouc Dept Hematooncol Olomouc Czech Republic;

  Univ Hosp Heidelberg Amyloidosis Ctr Med Dept 5 Neuenheimer Feld 410 D-69120 Heidelberg Germany;

  Palacky Univ Fac Med &

  Dent Dept Clin &

  Mol Pathol Olomouc Czech Republic;

  Univ Hosp Heidelberg Amyloidosis Ctr Med Dept 5 Neuenheimer Feld 410 D-69120 Heidelberg Germany;

  Univ Hosp Heidelberg Amyloidosis Ctr Med Dept 5 Neuenheimer Feld 410 D-69120 Heidelberg Germany;

  Univ Hosp Heidelberg Amyloidosis Ctr Med Dept 5 Neuenheimer Feld 410 D-69120 Heidelberg Germany;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病 ;
• 关键词